Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Revenue Summary of Clarus Therapeutics Holdings, Inc.

  • Clarus Therapeutics Holdings, Inc.'s latest annual revenue in 2021 was 13.95 Million USD , up 119.14% from previous year.
  • Clarus Therapeutics Holdings, Inc.'s latest quarterly revenue in 2022 Q2 was 4.05 Million USD , up 0.97% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported a annual revenue of 6.36 Million USD in annual revenue 2020, down 0.0% from previous year.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly revenue of 4.01 Million USD for 2022 Q1, down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly revenue of 13.95 Million USD for 2021 FY, up 119.14% from previous quarter.

Annual Revenue Chart of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Historical Annual Revenue of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Year Revenue Revenue Growth
2021 13.95 Million USD 119.14%
2020 6.36 Million USD 0.0%

Peer Revenue Comparison of Clarus Therapeutics Holdings, Inc.

Name Revenue Revenue Difference
AstraZeneca PLC 46.91 Billion USD 99.97%
Bristol-Myers Squibb Company PFD CONV 2 45 Billion USD 99.969%
CSPC Pharmaceutical Group Limited 31.45 Billion USD 99.956%
Novartis AG 46.66 Billion USD 99.97%
PT Kalbe Farma Tbk. 1.97 Billion USD 99.295%